健帆生物：11月24日召开董事会会议

Group 1 - The core point of the article is that Jianfan Biological announced an adjustment to its organizational structure during its board meeting held on November 24, 2025 [1] - For the year 2024, the revenue composition of Jianfan Biological is 99.71% from the medical device manufacturing industry and 0.29% from other sources [1] - As of the report date, Jianfan Biological has a market capitalization of 16.1 billion yuan [1] Group 2 - Dapeng Industrial's strategic placement has significantly benefited its insiders, with a subscription price of 9 yuan and a first-day listing price of 118 yuan, resulting in a paper profit of 24.92 million yuan for the controlling shareholder and his brother [1]